March 2017 Issue Table Of Contents

From The Editor

• Gender Diversity – Can Biopharma Do Better?

Feature Articles

• Grünenthal’s Plan To Grow Globally & Expand Its Pipeline
• Are You Ready To Serve On A Corporate Board?

Capitol Perspectives

• Pharmaceuticals Escape The Knife As GOP Mulls Medicaid Reform

Companies To Watch

• Edge Therapeutics

Inside The Industry

• The Uphill Battle Of A Biotech That Switched Its Focus
• Lack Of Real Estate Prompts Life Sciences To Get Creative
• Building A Biotech Hub – Austin Style
• Pfizer’s Response To Counterfeit Drugs
• Pharma Field Trips: Is Hosting The FDA A Good Idea?
• Why Xellia Revived A Shuttered Pharma Facility
• Academia Finds New Ways To Partner With Pharma
• New ADC Technologies: Deadlier For Tumors, Safer For Patients
• A Positive Outcome From Pharma Closures

Leadership Lessons

• Leading Courageously Through Unclear Times

Ask The Board

• Do You Use Dual Sourcing To Improve Security Of Purchased Materials Supply?
• What Are The Opportunities For Technology To Further Enhance Clinical Trial Operations?
• What Will Be Transformative To Facilitating Innovation In Biopharma?